Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b.
In a study of 29 patients who were receiving or had received interferon alpha 2b (IFN-alpha 2b) as maintenance therapy for multiple myeloma, antibodies were detected in 58% (17/29) of patients measured by a solid-phase enzyme-linked immunosorbent assay (ELISA). Only 7/17 patients who were positive f...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
1994
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033398/ |